Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helliwell

Showing results (1161-1170 of 1,256) with videos related to

Pageof 126
Sort By:
Trials|September 5, 2022
Efficacy and safety of guselkumab in biologic-naïve patients with active axial psoriatic arthritis: study protocol for STAR, a phase 4, randomized, double-blinded, placebo-controlled trialDafna D Gladman, Philip J Mease, Paul Bird, et al.
The Lancet. Public Health|April 24, 2022
Policy stringency and mental health during the COVID-19 pandemic: a longitudinal analysis of data from 15 countriesLara B Aknin, Bernardo Andretti, Rafael Goldszmidt, et al.
Annals of the Rheumatic Diseases|October 28, 2008
Treatment recommendations for psoriatic arthritisC T Ritchlin, A Kavanaugh, D D Gladman, et al.
The Journal of Rheumatology|July 7, 2023
Initiating Evaluation of Composite Outcome Measures for Psoriatic Arthritis: 2022 Updates From the GRAPPA-OMERACT Working GroupYing-Ying Leung, William Tillett, Maarten de Wit, et al.
Rheumatology (Oxford, England)|October 24, 2020
Treatment of psoriatic arthritis with biologic and targeted synthetic DMARDs: British Society for Rheumatology guideline scopeWilliam Tillett, Alexander Allen, Laura Tucker, et al.
The Journal of Rheumatology|February 12, 2010
Imaging in psoriasis and psoriatic arthritis: GRAPPA 2008Laura C Coates, Dennis M McGonagle, Richard Hodgson, et al.
Scientific Reports|December 3, 2021
Application of information theoretic feature selection and machine learning methods for the development of genetic risk prediction modelsFarideh Jalali-Najafabadi, Michael Stadler, Nick Dand, et al.
Scientific Reports|January 31, 2018
Preferential amplification of a human mitochondrial DNA deletion in vitro and in vivoOliver M Russell, Isabelle Fruh, Pavandeep K Rai, et al.
The Journal of Rheumatology|May 3, 2016
Report of the GRAPPA-OMERACT Psoriatic Arthritis Working Group from the GRAPPA 2015 Annual MeetingAna-Maria Orbai, Philip J Mease, Maarten de Wit, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 23, 2017
Genome-wide CRISPR screen for PARKIN regulators reveals transcriptional repression as a determinant of mitophagyChristoph Potting, Christophe Crochemore, Francesca Moretti, et al.
Pageof 126

Showing results (1161-1170 of 1,256) with videos related to

Sort By:
Pageof 126
Trials|September 5, 2022
Efficacy and safety of guselkumab in biologic-naïve patients with active axial psoriatic arthritis: study protocol for STAR, a phase 4, randomized, double-blinded, placebo-controlled trialDafna D Gladman, Philip J Mease, Paul Bird, et al.
The Lancet. Public Health|April 24, 2022
Policy stringency and mental health during the COVID-19 pandemic: a longitudinal analysis of data from 15 countriesLara B Aknin, Bernardo Andretti, Rafael Goldszmidt, et al.
Annals of the Rheumatic Diseases|October 28, 2008
Treatment recommendations for psoriatic arthritisC T Ritchlin, A Kavanaugh, D D Gladman, et al.
The Journal of Rheumatology|July 7, 2023
Initiating Evaluation of Composite Outcome Measures for Psoriatic Arthritis: 2022 Updates From the GRAPPA-OMERACT Working GroupYing-Ying Leung, William Tillett, Maarten de Wit, et al.
Rheumatology (Oxford, England)|October 24, 2020
Treatment of psoriatic arthritis with biologic and targeted synthetic DMARDs: British Society for Rheumatology guideline scopeWilliam Tillett, Alexander Allen, Laura Tucker, et al.
The Journal of Rheumatology|February 12, 2010
Imaging in psoriasis and psoriatic arthritis: GRAPPA 2008Laura C Coates, Dennis M McGonagle, Richard Hodgson, et al.
Scientific Reports|December 3, 2021
Application of information theoretic feature selection and machine learning methods for the development of genetic risk prediction modelsFarideh Jalali-Najafabadi, Michael Stadler, Nick Dand, et al.
Scientific Reports|January 31, 2018
Preferential amplification of a human mitochondrial DNA deletion in vitro and in vivoOliver M Russell, Isabelle Fruh, Pavandeep K Rai, et al.
The Journal of Rheumatology|May 3, 2016
Report of the GRAPPA-OMERACT Psoriatic Arthritis Working Group from the GRAPPA 2015 Annual MeetingAna-Maria Orbai, Philip J Mease, Maarten de Wit, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 23, 2017
Genome-wide CRISPR screen for PARKIN regulators reveals transcriptional repression as a determinant of mitophagyChristoph Potting, Christophe Crochemore, Francesca Moretti, et al.
Pageof 126